Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2010 Mar 1;107(11):5208–5213. doi: 10.1073/pnas.0913107107

Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5−/− mice

Barbara Colsoul a,1, Anica Schraenen b,1, Katleen Lemaire b, Roel Quintens b, Leentje Van Lommel b, Andrei Segal a, Grzegorz Owsianik a, Karel Talavera a, Thomas Voets a, Robert F Margolskee c, Zaza Kokrashvili c, Patrick Gilon d, Bernd Nilius a,2, Frans C Schuit b,2, Rudi Vennekens a,2,3
PMCID: PMC2841940  PMID: 20194741

Abstract

Glucose homeostasis is critically dependent on insulin release from pancreatic β-cells, which is strictly regulated by glucose-induced oscillations in membrane potential (Vm) and the cytosolic calcium level ([Ca2+]cyt). We propose that TRPM5, a Ca2+-activated monovalent cation channel, is a positive regulator of glucose-induced insulin release. Immunofluorescence revealed expression of TRPM5 in pancreatic islets. A Ca2+-activated nonselective cation current with TRPM5-like properties is significantly reduced in Trpm5−/− cells. Ca2+-imaging and electrophysiological analysis show that glucose-induced oscillations of Vm and [Ca2+]cyt have on average a reduced frequency in Trpm5−/− islets, specifically due to a lack of fast oscillations. As a consequence, glucose-induced insulin release from Trpm5−/− pancreatic islets is significantly reduced, resulting in an impaired glucose tolerance in Trpm5−/− mice.

Keywords: Ca2+ signaling, insulin release, pancreatic β-cells, transient receptor potential ion channels, glucose sensing


The pancreatic β-cell is an electrically excitable cell that secretes insulin when extracellular glucose levels exceed a threshold concentration. Characteristically, upon stimulation with glucose, β-cells display an oscillatory change of the membrane potential (Vm) and, in parallel, of the cytosolic Ca2+ level ([Ca2+]cyt) (14). This pattern, consisting of slow waves of depolarized plateaus on which bursts of action potentials are superimposed and separated by electrically silent intervals, plays a critical role in the regulation of insulin secretion. Indeed, in the absence of depolarization, no insulin is released, and the “extent” of electrical activity largely determines the amount of released insulin (1, 5). The bursting pattern of the β-cell is a complex interplay among different ion channels (e.g., ATP-sensitive K+ channels, voltage-gated Ca2+ channels, and Ca2+ and voltage-activated K+ channels), intracellular Ca2+ levels ([Ca2+]cyt), and the cellular metabolism of the β-cell (1, 6). The increase in [Ca2+]cyt originates from glucose-induced Ca2+ influx through voltage-gated L-type Ca2+ channels and, possibly, Ca2+ mobilization from intracellular stores, the latter promoted by activation of the phospholipase C system and generation of inositol 1,4,5-trisphosphate (1, 7, 8). Despite intensive investigation, several aspects of the rhythmic electrical activity of β-cells, such as the origin of the variability in oscillation pattern, remain unclear. Indeed, glucose stimulation can result in high-frequency short bursts, low-frequency long bursts, or a combination of these two patterns, also known as compound bursts (9, 10).

In this study we identified TRPM5 as a player in the electrical activity of glucose-stimulated pancreatic β-cells. TRPM5 is one of 28 members of the large transient receptor potential (TRP) superfamily (1113). TRPM5, and its close homologue TRPM4, are Ca2+-activated cation channels that are permeable for monovalent cations, but not divalent cations, with a conductance of approximately 20 to 25 pS (1416). Using Trpm5−/− mice we show here that this channel promotes high-frequency glucose-induced oscillations in Vm and [Ca2+]cyt in pancreatic β-cells. Loss of TRPM5 expression, and high-frequency bursting, is functionally relevant as this leads to reduced glucose-induced insulin release from isolated islets and impaired glucose tolerance.

Results and Discussion

Expression of the Trpm5 Gene in Pancreatic β-Cells.

Previously, Trpm5 expression was shown on the mRNA level in several β-cell lines and in human and mouse tissues, including taste buds, intestine, and pancreatic islets (13, 1722). Here we describe immunostaining of TRPM5 protein in pancreatic islets with a specific antibody (Fig. 1). TRPM5 is colocalized with insulin in WT islets, strongly suggesting expression of TRPM5 in insulin secreting β-cells. Specific staining with the TRPM5 antibody is absent in Trpm5−/− islets. Quantitative PCR experiments in a purified β-cell sample confirmed expression of Trpm5 in the β-cells. Expression of Trpm5 could also be detected in purified α-cells, although to a lower level compared with β-cells (Fig. S1).

Fig. 1.

Fig. 1.

Expression of TRPM5 protein in pancreatic islets of Langerhans immunostaining for TRPM5 and insulin of pancreatic islets from WT and Trpm5−/− mice.

Characterization of a Ca2+ Release–Activated Cation Current in Pancreatic Islet Cells.

To determine whether TRPM5 is part of the Ca2+-activated monovalent cation current described earlier in insulin-secreting cell lines and primary β-cells (2325), we compared whole-cell currents in WT and Trpm5−/− single pancreatic islet cells. Only cells with a cell capacitance of >5 pF were analyzed, being most likely pancreatic β-cells (26). In one approach, cells were dialyzed with a pipette solution containing 1.5 μM Ca2+. As shown in Fig. 2, a Ca2+-dependent cation current can be readily activated, which is largely reduced in Trpm5−/− cells (Fig. 2 AC). Comparable results were obtained when [Ca2+]cyt was increased by flash-uncaging during whole-cell experiments (WT, 6.5 ± 1.4 pA/pF; vs. Trpm5−/−, 3.5 ± 0.5 pA/pF; P = 0.035 at −80 mV; WT, 2.53 ± 0.7 pA/pF; vs. Trpm5−/−, 1.09 ± 0.2 pA/pF; P = 0.025 at +80 mV; n = 21–27 from five to six mice). Ca2+ uncaging during a step to +80 mV (Fig. 2D) allows determination of the time course of activation for this current, in relative isolation from other conductances in β-cells. In WT cells we found a time constant for activation (τ = 24.1 ± 3.5 ms; n = 14), which is similar to what has been shown before for TRPM5 (27). Furthermore, the Ca2+-activated current in these conditions in WT cells showed a clear bell-shaped dependency on [Ca2+]cyt (Fig. 2F), which corresponds to the Ca2+-dependence of TRPM5 (13, 27). Obviously, the current in Trpm5−/− cells is strongly reduced at each [Ca2+]cyt level (Fig. 2 C and F). Finally, the Ca2+-activated current in WT cells displayed a cation conductance sequence Li+>Na+>>Ca2+∼NMDG+, which is essentially the same as reported for TRPM5, but different from the background current in Trpm5−/− cells (Na+>Li+>>Ca2+∼NMDG+). Thus, it is clear that TRPM5 is an important constituent of the calcium-activated cation current in pancreatic β-cells. Other presently known molecular candidates for this class of ion channels include TRPC5 (28, 29), TRPM2 (30), and TRPM4, which may constitute the remaining Ca2+-activated cation current in Trpm5−/− β-cells. At least TRPM2 and TRPM4 are also expressed in insulin-secreting cell lines and in mouse pancreatic islets (31, 32). Notably, deletion of the Trpm4 gene has no effect on glucose tolerance or on insulin release from pancreatic islets (33). Finally, note that the current described here is fundamentally different from the “leak” channel, NALCN, proposed recently in β-cells (34, 35).

Fig. 2.

Fig. 2.

Characterization of a TRPM5-dependent calcium-activated nonselective cation current in single pancreatic islet cells. (A) Representative current traces in response to voltage ramps from −125 mV to +125 mV in WT cells dialyzed with either 0 or 1.5 μM Ca2+ in a bath solution containing 150 mM Na+ or 150 mM NMDG+. (B) Representative current traces as in A in Trpm5−/− cells. (C) Mean current densities at +80 mV and −80 mV in WT and Trpm5−/− cells (n = 12–14) in response to 0 Ca or 1.5 μM Ca2+ as in A. (D) Representative example of a current measured in a WT cell in the whole cell configuration during a step at +80 mV showing the activation kinetics of the calcium-activated current. After 60 ms, flash photolysis of caged Ca2+ was performed (arrow). [Ca2+]cyt was measured simultaneously. (E) Representative example of a current measured as in D in a Trpm5−/− cell. (F) Ca2+ dependency of the current activated after uncaging of Ca2+ at +80 mV in WT and Trpm5−/− cells. The response is the difference in current density before and after the flash photolysis and is obtained from experiments as shown in D and E. *P < 0.05.

Slower Intracellular Ca2+ Oscillations in Islets Derived from Trpm5−/− Mice.

To find clues about the functional role of TRPM5 in pancreatic β-cells, we first turned to glucose-induced Ca2+ oscillations. β-Cells display very characteristic [Ca2+]cyt oscillations in response to high glucose concentrations, which critically regulate the release of insulin. To analyze glucose-induced signaling in intact islets, we monitored [Ca2+]cyt dynamics in intact Fura-2–loaded islets of WT and Trpm5−/− mice. The basal fura-2 fluorescence ratio (F350/F380), in a nonstimulatory glucose concentration (3 mM), was similar in WT and Trpm5−/− islets (WT, 1.16 ± 0.03; vs. Trpm5−/−, 1.20 ± 0.02; P = 0.16; n = 27–33 from five to seven mice). Islets from both genotypes had a similar glucose concentration threshold for triggering [Ca2+]cyt oscillations (WT, 6.20 ± 0.243; vs. Trpm5−/−, 6.21 ± 0.239; P = 0.97; n = 14–15 from four to five mice), indicating that glucose metabolism preceding glucose-induced electrical activity is not changed in Trpm5−/− mice.

Increasing extracellular glucose concentration from 3 to 10 mM elicited an oscillatory increase in [Ca2+]cyt in both WT and Trpm5−/− islets (Fig. 3A). During a typical 20-min stimulation with 10 mM glucose, the average increase in [Ca2+]cyt, as evaluated from F350/F380, was not different between WT and Trpm5−/− islets (WT, 0.26 ± 0.03; vs. Trpm5−/−, 0.21 ± 0.02; P = 0.23; n = 28–33 from five to seven mice; Fig. 3B). Strikingly, Trpm5−/− islets exhibited overall a significantly lower frequency of [Ca2+]cyt oscillations (0.82 ± 0.11 peaks/min in WT; 0.38 ± 0.03 peaks/min in Trpm5−/− islets; P = 0.00078; n = 28–34 from five to seven mice; Fig. 3C).

Fig. 3.

Fig. 3.

Overall reduced frequency of intracellular Ca2+ oscillations in isolated islets from Trpm5−/− mice as a result of a lack of fast oscillations. (A) Effect of glucose (10 mM) on the [Ca2+]cyt in islets from WT and Trpm5−/− mice. Initially, the islets were bathed in a solution containing 3 mM glucose. Arrows indicate application of 10 mM glucose. (B) Average increase in ratio (F350/F380) after stimulation with 10 mM glucose in islets from WT and Trpm5−/− mice (n = 28–34 from five to seven mice; P = 0.23). (C) Frequency of oscillations in individual experiments from WT and Trpm5−/− islets, counted as the number of peaks per min (n = 28–34 from five to seven mice). [Ca2+]cyt increase of 15% was considered to be an oscillation, when 100% is the amplitude between the baseline and the highest level reached in 10 mM glucose. ***P < 0.001. (D) Proportion of islets showing slow, mixed, and fast oscillation patterns according to Fourier analysis in WT (38.2%, 38.2%, and 23.6%, respectively) and Trpm5−/− islets (89.3%, 10.7%, and 0%, respectively): n = 28 to 34 from five to seven mice; χ2 analysis WT vs. Trpm5−/−: P = 0.0006.

However, in line with previous work (10, 36, 37), we observed significant variability in the oscillatory pattern among individual islets. Using Fourier analysis, three different oscillatory patterns could be distinguished in WT islets in 10 mM glucose (Fig. S2) (i): slow oscillators display relevant frequencies below 0.015 Hz (ii), fast oscillators display relevant frequencies above 0.015 Hz, and (iii) mixed (compound) oscillators display relevant frequencies in both slow and fast frequency regions (for a detailed description, see Fig. S2). In preparations from WT mice, the proportion of islets exhibiting slow (38.2%), mixed (38.2%), and fast (23.6%) [Ca2+]cyt oscillations (Fig. 3D) was comparable to distributions reported before (10, 37). Remarkably, fast oscillating islets were completely lacking in preparations from Trpm5−/− mice, in which 89.3% of the islets were classified as slow oscillators and the remaining islets showed mixed oscillations (χ2 analysis, P = 0.0006; Fig. 3D). An analogous difference is observed when islets were stimulated with a supramaximal concentration of glucose (20 mM). This leads to longer plateaus of increased Ca2+, both in WT and KO islets. In WT islets, a sustained Ca2+ plateau is the most prevalent pattern, whereas Ca2+ oscillations during the stimulation period were observed in only a small subset of the islets. Strikingly, in Trpm5−/− islets, the oscillating pattern is the more prevalent (Fig. S3; χ2 analysis, P = 0.025). Finally, it should be noted that increased glucose-induced [Ca2+]cyt oscillation frequency in β-cells lacking the BETA3 subunit of voltage-gated Ca2+ channels can be accounted for by enhanced formation of inositol 1,4,5-trisphosphate and increased Ca2+ mobilization from intracellular stores in Beta3−/− islets (38). In Trpm5−/− islets, this pathway is not altered, as release of calcium from the intracellular stores was the same in WT and Trpm5−/− islets upon stimulation with acetylcholine [an activator of the phospholipase C pathway (39); Fig. S4], revealing no differences in the PI signaling pathway or the amount of Ca2+ in intracellular stores. Taken together, these data demonstrate that TRPM5 is specifically required for the generation of fast [Ca2+]cyt oscillations upon high glucose stimulation.

Membrane Potential Oscillations from WT and Trpm5−/− Islets.

As TRPM5 is a Ca2+-activated, but Ca2+-impermeable, cation channel, it can be anticipated that TRPM5 will influence [Ca2+]cyt oscillations through an effect on membrane potential (Vm). Typically, glucose-stimulated pancreatic islets display depolarizing oscillations of membrane potential triggering bursts of action potentials (Fig. 4A). Oscillations in intracellular Ca2+ and Vm in glucose-stimulated islets are strictly coupled (Fig. S5A). Therefore, we performed combined Vm and [Ca2+]cyt measurements, to unravel the role of TRPM5 in this process.

Fig. 4.

Fig. 4.

Vm measurements in WT and Trpm5−/− islets stimulated with 10 mM glucose. (A) Representative examples of Vm measurements in WT islets showing fast (Left) and slow (Middle) oscillation patterns and in Trpm5−/− islets displaying slow oscillations (Right). (B) Comparison of duration of the interburst interval, threshold potential for burst initiation, and slope of the depolarization during the interburst interval in WT fast- and slow-oscillating islets and in Trpm5−/− slow-oscillating islets (n = 8–9 from five to six mice). *P < 0.05; ***P < 0.001.

In line with the pattern of [Ca2+]cyt oscillations, glucose-induced Vm oscillations in individual islets can be classified as slow (average frequency <0.015 Hz), fast (average frequency >0.015 Hz; Fig. 4A), or mixed, showing the typical pattern of clusters of Vm oscillations separated by prolonged silent intervals (40). In a group of WT islets (n = 17), the distribution of the different oscillation patterns was comparable to the distribution seen in [Ca2+]cyt measurements (χ2 analysis, P = 0.09): 47% of the islets were oscillating fast (n = 8), whereas 41.2% could be classified as slow oscillators (n = 7) and the remaining 11.8% (n = 2) showed compound oscillations. Likewise, Trpm5−/− islets (n = 9; χ2 analysis, P = 0.3), only display slow oscillations. Thus, it is clear that the absence of fast [Ca2+]cyt oscillations is mirrored by the absence of fast Vm oscillations in Trpm5−/− islets (Fig. 4A; χ2 analysis, WT vs. Trpm5−/−, P = 0.019).

To determine the contribution of TRPM5 to the bursting pattern in glucose-stimulated islets, we performed a detailed comparison of Vm changes in islets from both mouse strains. Detailed analysis of the individual action potentials on top of the depolarized plateau, revealed no significant differences between WT and Trpm5−/− islets concerning parameters like duration and maximal slope of the upstroke, duration of repolarization, and width at half-maximal amplitude. A tendency, although not statistically significant, toward reduced action potential amplitude was apparent in Trpm5−/− islets (Table S1 and Fig. S6). Slow burst oscillations were indistinguishable between WT and Trpm5−/− islets, with respect to the duration of the interburst interval, the slope of depolarization during the interburst interval, the threshold potential for burst initiation (Fig. 4B), the average burst duration, plateau fraction, resting potential, interburst potential, and the plateau potential (Table 1). As fast bursting is missing from Trpm5−/− mice, it seems evident that TRPM5 activity must be hidden in the difference between fast and slow bursting in WT islets. The most obvious differences in that comparison are burst duration, interburst interval, and maximal slope of the interburst interval. Burst duration is significantly shorter in fast oscillating islets compared with slow islets (Table 1). This is, however, unlikely to result from a lack of TRPM5 activity, as a Ca2+-activated cation channel would be expected to prolong the burst duration. Furthermore, in agreement with the unchanged average [Ca2+]cyt increase in Trpm5−/− islets, the plateau fraction is similar in all groups (Table 1). Fast oscillators display a significantly shorter interburst interval, resulting in higher burst frequency. In parallel, the maximal slope of the interburst interval is significantly increased in fast oscillating islets compared with slow islets. It is clear from combined [Ca2+]cyt and Vm measurements that the Ca2+-transient overlaps with the interburst interval (Fig. S5A), so it is likely that TRPM5 is active during the interburst interval. As the increased slope is lacking in Trpm5−/− islets, our data strongly suggest that TRPM5 is contributing to the depolarizing current during the interburst interval to drive the Vm toward the threshold for a new burst of activity.

Table 1.

Characteristics of Vm measurements in WT and Trpm5−/− islets during stimulation with 10 mM glucose

Characteristic WT Trpm5−/−:Slow (n = 9 from 5 mice) P value
Slow (n = 7 from 5 mice) Fast (n = 8 from 6 mice) WT: Slow vs. fast Slow: WT vs. Trpm5−/−
Duration of interburst interval, s 180.8 ± 55.4 11.8 ± 1.4 153.5 ± 34.0 0.013* 0.78
Slope of depolarization in the interburst interval, mV/s 0.023 ± 0.004 0.13 ± 0.02 0.034 ± 0.01 0.0001* 0.18
Threshold potential for burst initiation, mV −56.9 ± 1.1 −54.3 ± 2.1 −59.1 ± 2.4 0.27 0.64
Average duration of burst plateau, s 120.5 ± 17.6 12.7 ± 3.5 114.7 ± 17.4 <0.0001* 0.82
Plateau fraction, % 0.47 ± 0.04 0.55 ± 0.06 0.6 ± 0.05 0.22 0.56
Plateau potential, mV −42.2 ± 2.5 −49.2 ± 3.0 −46.2 ± 4.4 0.091 0.41
Interburst potential, mV −61.2 ± 2.3 −59.4 ± 2.72 −66.7 ± 1.5 0.61 0.14
Resting potential, mV −70.4 ± 0.8 −71.5 ± 1.0 −73.0 ± 2.1 0.12 0.98

Comparison of different parameters (in mean ± SEM) of Vm in WT slow (n = 7 from 5 mice) vs. WT fast (n = 8 from 6 mice) oscillating islets and WT slow vs. Trpm5−/− slow oscillating islets (n = 9 from 5 mice). The plateau fraction is calculated as the sum of burst lengths divided by the total period of glucose stimulation.

*Significant at P < 0.05.

Interestingly, a mathematical model of Ca2+ and Vm changes in a glucose-stimulated pancreatic β-cell reproduces this phenotype (Fig. S5B). In this model, removing a Ca2+-activated monovalent cation conductance significantly reduces the oscillation frequency, as we observe in our KO mouse model. This is a result of the lack of a depolarizing current in the interburst interval, which shapes the slow depolarization of the membrane potential to reach the threshold for a new burst of activity (Fig. S5C). Note that the increased Ca2+ during the burst of activity overlaps to a large part with the interburst interval, as we also observe in simultaneous Ca2+ and Vm measurements (Fig. S5 A and B), explaining why TRPM5 would be active in this period.

It's important to mention here, however, that it is unclear what the exact mechanism behind the variability of the oscillation pattern of a pancreatic islet is (9), and why TRPM5 is apparently only functionally relevant in a (fast-oscillating) subpopulation of the islets. Several models for glucose-induced Ca2+ oscillations exist, of which the most successful propose a complex interplay among [Ca2+]cyt levels, ion channel activity, glycolytic rate, and mitochondrial respiration (6). Bertram et al. (6) propose that slow oscillations (period between 2 and 7 min) represent oscillations in glycolytic activity and that fast oscillations (period as long as tens of seconds) are controlled by ion channel activity during persistent high glycolytic activity. Compound bursting would represent a complex interplay among several of the aforementioned factors. Our data fit well into this model, in a sense that we can show that TRPM5 is essential for the occurrence of fast but not slow oscillations and that also compound bursting is largely lacking in Trpm5−/− islets. An interesting hypothesis might be that the weight of TRPM5-mediated depolarization is coupled to the glycolytic rate in the cell. Thus, at a constantly high glycolytic rate, which is a necessity for fast oscillations according to Bertram et al. (6), TRPM5 activity would be able to depolarize Vm in the interburst interval, as the hyperpolarizing KATP current is largely inactive at that point. Conversely, during an oscillating glycolytic rate, TRPM5 would be inadequate to depolarize Vm during the low point of glycolytic activity, corresponding to the interburst interval between slow oscillations (6) as a result of high activity of KATP.

Metabolic Phenotype of Trpm5−/− Mice.

To determine whether the lack of fast oscillations has consequences for pancreatic islet function, glucose-induced insulin release from freshly isolated islets was measured. Insulin release was significantly reduced in Trpm5−/− islets when stimulated with 10 or 20 mM glucose (Fig. 5A and Fig. S5). Importantly, the insulin content of individual islets (WT, 65.9 ± 5.5 ng insulin/islet; vs. Trpm5−/−, 57.2 ± 5.2 ng insulin/islet; P = 0.27; n = 8) and the pancreatic insulin content in Trpm5−/− islets (WT, 45.9 ± 6.6 μg insulin per pancreas; vs. Trpm5−/−, 51 ± 6.8 μg insulin per pancreas; P = 0.58; and WT, 90.8 ± 12.7 μg insulin per g of pancreas; vs. Trpm5−/−, 105.1 ± 1.3 μg insulin per g of pancreas; P = 0.38; n = 3) were unchanged, indicating that TRPM5 is not required for insulin synthesis or storage. β-Cells release insulin through Ca2+-dependent exocytosis of membrane vesicles (41). Cell capacitance measurements from isolated β-cells reveal a similar exocytotic response to the Ca2+-ionophore ionomycin (ΔCm, 0.70 ± 0.26 pF in WT cells vs. 0.74 ± 0.18 pF in Trpm5−/− cells; P = 0.77; n = 6 per group), excluding a defect in Ca2+-dependent exocytosis as a result of Trpm5 gene deletion. Considering that the time-averaged [Ca2+]cyt signal (and the plateau fraction in Vm measurements) upon glucose stimulation was not significantly different from WT, it may seem difficult to explain a significant reduction in Ca2+-dependent insulin release. However, in this aspect, our results are fully consistent with previous work in β-cells (38) as well as in other secretory cell types such as pulmonary alveolar cells (42) and somatotropes (43), showing that fast Ca2+ oscillations are more efficient than slow oscillations in triggering exocytosis of secretory vesicles. It is clear that Ca2+ exhibits a strong cooperativity in triggering exocytosis from β-cells, suggesting that four to five Ca2+ ions bind to the exocytotic machinery to induce vesicle fusion (44). This nonlinearity may, at least partially, underlie the more efficient insulin release in rapidly oscillating islets. Moreover, oscillatory changes in [Ca2+]cyt in β-cells were also shown to be much more efficient than sustained changes in mobilizing and/or priming vesicles for release (38).

Fig. 5.

Fig. 5.

Reduced glucose-induced insulin release leads to a disturbed glucose tolerance in Trpm5−/− mice. (A) Insulin secretion from WT and Trpm5−/− islets. Islets were challenged with different glucose concentrations as indicated (n = 8 per group). Insulin release was normalized to islet insulin content. *P < 0.05. (B) Plasma insulin levels after an i.p. glucose injection in overnight fasted WT and Trpm5−/− mice (n = 4–5 mice; *P < 0.05; **P < 0.01). (C) OGTT and IPGTT glucose tolerance tests in WT and Trpm5−/− mice. (n = 7 WT and n = 7 Trpm5−/− mice for OGTT, n = 4 WT and n = 4 Trpm5−/− mice for IPGTT. *P < 0.05; **P < 0.01.)

Finally, in conscious mice, overnight fasting blood glucose levels were significantly higher in Trpm5−/− mice (95 ± 3 mg/dL) versus WT mice (72 ± 2 mg/dL; n = 25–28; P = 0.0009). No changes were observed between both mouse lines in an insulin tolerance test (Fig. S7). However, in agreement with the reduced insulin release measured from isolated islets, plasma insulin levels after i.p. glucose injection in overnight fasted male mice were significantly reduced in Trpm5−/− mice compared with WT mice (Fig. 5B). As a consequence, results of oral glucose tolerance test (OGTT) and i.p. glucose tolerance test (IPGTT) show a reduced glucose tolerance in Trpm5−/− mice (Fig. 5C). These data convincingly show that reduced glucose-induced insulin release from β-cells leads to a moderate but significant glucose intolerance in Trpm5−/− mice.

Conclusion

We identified Trpm5 as an important gene for the function of mouse pancreatic β-cells. Deletion of Trpm5 results in an impaired glucose tolerance caused by a reduced glucose-induced insulin release from pancreatic islets. In this way, insight in pancreatic TRPM5 function could consolidate our understanding of the pathogenesis of type II diabetes and might provide a unique target for the treatment of this disease.

Materials and Methods

Experimental procedures are described in more detail in SI Materials and Methods.

Mice.

Trpm5−/− mice (45) were backcrossed eight generations in the C57BL/6J background and WT C57BL/6J mice were used as controls. Only male mice were used for experiments. All animal experiments were carried out in accordance with the European Union Community Council guidelines and approved by the local ethics committee.

Preparation of Islets.

Islets were isolated from male mice at 10 to 14 weeks of age via collagenase digestion as described previously (46).

Solutions.

For whole-cell current measurements, pipette solution contained (in mM) 20 NaCl, 120 NaAsp, 10 Hepes. MgCl2, CaCl2, and the appropriate Ca2+ buffer were added according to the CaBuf program (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip) to obtain 1 mM free Mg2+ and the desired free Ca2+-concentration. Bath solution contained (in mM) 150 NaCl, 5 MgCl2, 10 Hepes, and 10 glucose. Pipette solution for flash-uncaging contained (in mM) 20 CsCl, 120 CsAsp, 20 Hepes, 2 CaCl2, 5 DMNP-EDTA [1-(4.5-dimethoxy-2-nitrophenyl)-EDTA, Molecular Probes], 1 Fura-2FF (Teflabs); and bath solution contained (in mM) 140 CsAsp, 5 MgCl2, 10 Hepes, 10 glucose, 1 μM nifedipine (Sigma-Aldrich) and 100 nM tetrodotoxin (Sankyo). Standard extracellular solution for calcium imaging measurements contained (in mM): 120 NaCl, 4.8 KCl, 2.5 CaCl2, 1.2 MgCl2, 10 Hepes, pH 7.4, with NaOH, with different concentrations of glucose added as indicated. For Vm and combined measurements, bath solution contained (in mM): 138 NaCl, 5.6 KCl, 1.2 MgCl2, 2.6 CaCl2, 10 Hepes, pH 7.4, with NaOH; and pipette solution contained (in mM): 10 KCl, 10 NaCl, 70 K2SO4, 7 MgCl2, 5 Hepes, pH 7.35, with KOH, 300 μg/mL nystatin (Sigma-Aldrich) (47).

Electrophysiology and Calcium Measurements.

Whole cell currents were measured at 31 °C to 33 °C from cells with a capacitance >5 pF (WT, 6.6 ± 0.3 pF; vs. Trpm5−/−, 6.9 ± 0.3 pF; P = 0.42; n = 29–37), being most likely β-cells (26). [Ca2+]cyt was measured by monitoring the Fura-2FF fluorescence signal (F350/F380). Calibration of the fura signal was done as previously described (27). Ramp protocol consisted of a 400-ms ramp from −100 mV toward +100 mV (whole cell current measurements) applied at 1 Hz or from +100 mV toward −100 mV (calcium uncaging), applied at 0.5 Hz (holding potential, 0 mV). Flash photolysis was performed after 60 ms during a 300-ms depolarizing step at +80 mV. [Ca2+]cyt from Fura-2–loaded islets was measured monitoring fluorescence ratio (F350/F380) every second (after correction for background fluorescence) at 37 °C. Vm measurements were performed at 31 °C to 33 °C in the perforated patch configuration under current-clamp conditions. In combined measurements, Vm of a single cell within the islet and [Ca2+]cyt of a region centered around the patch pipette were simultaneously monitored.

Glucose and Insulin Tolerance Tests.

Glucose and insulin tolerance were analyzed in overnight-fasted and 6 h–fasted mice of 10–14 weeks age, respectively.

Insulin Release.

Insulin release was measured from statically incubated, size-matched, freshly isolated islets using a commercially available ELISA kit (Mercodia).

Data Analysis.

Origin software (version 7.0; OriginLab) was used for data analysis. Data are represented as mean ± SEM unless mentioned differently. Statistical analysis was performed with the Student t test unless mentioned differently. P < 0.05 was considered to represent a significant difference.

Supplementary Material

Supporting Information

Acknowledgments

We thank C. Zuker (University of California, San Diego) for providing the Trpm5−/− mice and Mikaela Granvik, Melissa Benoit, and Annelies Janssens for excellent technical assistance. This work was supported by a postdoctoral fellowship from the FWO Vlaanderen to K.L. and K.T.; research grants of the European Union (EURODIA FP6-518153), Belgian Ministry for Science Policy (Interuniversity Attraction Pole IUAP P6/40 and P6/28), Excellentiefinanciering EF/95/010, Research Foundation–Flanders (G.0172.03, 1.5.206.09 and G.0565.07), and Katholieke Universiteit Leuven (Geconcerteerde Onderzoeksacties GOA 2004/07, 2004/11, 2008/16); and by National Institutes of Health Grant DC03055 (to R.M. and Z.K.).

Footnotes

*This Direct Submission article had a prearranged editor.

The authors declare no conflict of interest.

This article contains supporting information online at www.pnas.org/cgi/content/full/0913107107/DCSupplemental.

References

  • 1.Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol. 1989;54:87–143. doi: 10.1016/0079-6107(89)90013-8. [DOI] [PubMed] [Google Scholar]
  • 2.Hinke SA, Hellemans K, Schuit FC. Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal. J Physiol. 2004;558:369–380. doi: 10.1113/jphysiol.2004.064881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.MacDonald PE, Rorsman P. Oscillations, intercellular coupling, and insulin secretion in pancreatic beta cells. PLoS Biol. 2006;4:e49. doi: 10.1371/journal.pbio.0040049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wiederkehr A, Wollheim CB. Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic beta-cell. Cell Calcium. 2008;44:64–76. doi: 10.1016/j.ceca.2007.11.004. [DOI] [PubMed] [Google Scholar]
  • 5.Henquin JC, Meissner HP. Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells. Experientia. 1984;40:1043–1052. doi: 10.1007/BF01971450. [DOI] [PubMed] [Google Scholar]
  • 6.Bertram R, Sherman A, Satin LS. Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion. Am J Physiol Endocrinol Metab. 2007;293:E890–E900. doi: 10.1152/ajpendo.00359.2007. [DOI] [PubMed] [Google Scholar]
  • 7.Berggren PO, Larsson O. Ca2+ and pancreatic B-cell function. Biochem Soc Trans. 1994;22:12–18. doi: 10.1042/bst0220012. [DOI] [PubMed] [Google Scholar]
  • 8.Barker CJ, Leibiger IB, Leibiger B, Berggren PO. Phosphorylated inositol compounds in beta -cell stimulus-response coupling. Am J Physiol Endocrinol Metab. 2002;283:E1113–E1122. doi: 10.1152/ajpendo.00088.2002. [DOI] [PubMed] [Google Scholar]
  • 9.Nunemaker CS, et al. Glucose modulates [Ca2+]i oscillations in pancreatic islets via ionic and glycolytic mechanisms. Biophys J. 2006;91:2082–2096. doi: 10.1529/biophysj.106.087296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Liu YJ, Tengholm A, Grapengiesser E, Hellman B, Gylfe E. Origin of slow and fast oscillations of Ca2+ in mouse pancreatic islets. J Physiol. 1998;508:471–481. doi: 10.1111/j.1469-7793.1998.471bq.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165–217. doi: 10.1152/physrev.00021.2006. [DOI] [PubMed] [Google Scholar]
  • 12.Nilius B, Voets T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflugers Arch. 2005;451:1–10. doi: 10.1007/s00424-005-1462-y. [DOI] [PubMed] [Google Scholar]
  • 13.Prawitt D, et al. TRPM5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i. Proc Natl Acad Sci U S A. 2003;100:15166–15171. doi: 10.1073/pnas.2334624100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hofmann T, Chubanov V, Gudermann T, Montell C. TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent selective cation channel. Curr Biol. 2003;13:1153–1158. doi: 10.1016/s0960-9822(03)00431-7. [DOI] [PubMed] [Google Scholar]
  • 15.Launay P, et al. TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002;109:397–407. doi: 10.1016/s0092-8674(02)00719-5. [DOI] [PubMed] [Google Scholar]
  • 16.Nilius B, et al. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003;278:30813–30820. doi: 10.1074/jbc.M305127200. [DOI] [PubMed] [Google Scholar]
  • 17.Fonfria E, et al. Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res. 2006;26:159–178. doi: 10.1080/10799890600637506. [DOI] [PubMed] [Google Scholar]
  • 18.Prawitt D, et al. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Hum Mol Genet. 2000;9:203–216. doi: 10.1093/hmg/9.2.203. [DOI] [PubMed] [Google Scholar]
  • 19.Kaske S, et al. TRPM5, a taste-signaling transient receptor potential ion-channel, is a ubiquitous signaling component in chemosensory cells. BMC Neurosci. 2007;8:49. doi: 10.1186/1471-2202-8-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kokrashvili Z, et al. Release of endogenous opioids from duodenal enteroendocrine cells requires Trpm5. Gastroenterology. 2009;137:598–606. doi: 10.1053/j.gastro.2009.02.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Enklaar T, et al. Mtr1, a novel biallelically expressed gene in the center of the mouse distal chromosome 7 imprinting cluster, is a member of the Trp gene family. Genomics. 2000;67:179–187. doi: 10.1006/geno.2000.6234. [DOI] [PubMed] [Google Scholar]
  • 22.Pérez CA, et al. A transient receptor potential channel expressed in taste receptor cells. Nat Neurosci. 2002;5:1169–1176. doi: 10.1038/nn952. [DOI] [PubMed] [Google Scholar]
  • 23.Roe MW, et al. Characterization of a Ca2+ release-activated nonselective cation current regulating membrane potential and [Ca2+]i oscillations in transgenically derived beta-cells. J Biol Chem. 1998;273:10402–10410. doi: 10.1074/jbc.273.17.10402. [DOI] [PubMed] [Google Scholar]
  • 24.Leech CA, Habener JF. A role for Ca2+-sensitive nonselective cation channels in regulating the membrane potential of pancreatic beta-cells. Diabetes. 1998;47:1066–1073. doi: 10.2337/diabetes.47.7.1066. [DOI] [PubMed] [Google Scholar]
  • 25.Sturgess NC, Hales CN, Ashford ML. Calcium and ATP regulate the activity of a non-selective cation channel in a rat insulinoma cell line. Pflugers Arch. 1987;409:607–615. doi: 10.1007/BF00584661. [DOI] [PubMed] [Google Scholar]
  • 26.Barg S, Galvanovskis J, Göpel SO, Rorsman P, Eliasson L. Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes. 2000;49:1500–1510. doi: 10.2337/diabetes.49.9.1500. [DOI] [PubMed] [Google Scholar]
  • 27.Ullrich ND, et al. Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium. 2005;37:267–278. doi: 10.1016/j.ceca.2004.11.001. [DOI] [PubMed] [Google Scholar]
  • 28.Blair NT, Kaczmarek JS, Clapham DE. Intracellular calcium strongly potentiates agonist-activated TRPC5 channels. J Gen Physiol. 2009;133:525–546. doi: 10.1085/jgp.200810153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gross SA, et al. TRPC5 is a Ca2+ -activated channel functionally coupled to Ca2+ -selective ion channels. J Biol Chem. 2009;284:34423–34432. doi: 10.1074/jbc.M109.018192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Du J, Xie J, Yue L. Intracellular calcium activates TRPM2 and its alternative spliced isoforms. Proc Natl Acad Sci USA. 2009;106:7239–7244. doi: 10.1073/pnas.0811725106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lange I, et al. TRPM2 functions as a lysosomal Ca2+-release channel in beta cells. Sci Signal. 2009;2:ra23. doi: 10.1126/scisignal.2000278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cheng H, et al. TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium. 2007;41:51–61. doi: 10.1016/j.ceca.2006.04.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vennekens R, et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol. 2007;8:312–320. doi: 10.1038/ni1441. [DOI] [PubMed] [Google Scholar]
  • 34.Swayne LA, et al. The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line. EMBO Rep. 2009;10:873–880. doi: 10.1038/embor.2009.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gilon P, Rorsman P. NALCN: a regulated leak channel. EMBO Rep. 2009;10:963–964. doi: 10.1038/embor.2009.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gilon P, Shepherd RM, Henquin JC. Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J Biol Chem. 1993;268:22265–22268. [PubMed] [Google Scholar]
  • 37.Bergsten P, Grapengiesser E, Gylfe E, Tengholm A, Hellman B. Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets. J Biol Chem. 1994;269:8749–8753. [PubMed] [Google Scholar]
  • 38.Berggren PO, et al. Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosis. Cell. 2004;119:273–284. doi: 10.1016/j.cell.2004.09.033. [DOI] [PubMed] [Google Scholar]
  • 39.Winzell MS, Ahrén B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Ther. 2007;116:437–448. doi: 10.1016/j.pharmthera.2007.08.002. [DOI] [PubMed] [Google Scholar]
  • 40.Beauvois MC, et al. Glucose-induced mixed [Ca2+]c oscillations in mouse beta-cells are controlled by the membrane potential and the SERCA3 Ca2+-ATPase of the endoplasmic reticulum. Am J Physiol Cell Physiol. 2006;290:C1503–C1511. doi: 10.1152/ajpcell.00400.2005. [DOI] [PubMed] [Google Scholar]
  • 41.Rorsman P, et al. The Cell Physiology of Biphasic Insulin Secretion. News Physiol Sci. 2000;15:72–77. doi: 10.1152/physiologyonline.2000.15.2.72. [DOI] [PubMed] [Google Scholar]
  • 42.Ashino Y, Ying X, Dobbs LG, Bhattacharya J. [Ca(2+)](i) oscillations regulate type II cell exocytosis in the pulmonary alveolus. Am J Physiol Lung Cell Mol Physiol. 2000;279:L5–L13. doi: 10.1152/ajplung.2000.279.1.L5. [DOI] [PubMed] [Google Scholar]
  • 43.Holl RW, et al. Spontaneous oscillations of intracellular calcium and growth hormone secretion. J Biol Chem. 1988;263:9682–9685. [PubMed] [Google Scholar]
  • 44.Eliasson L, et al. Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol. 2008;586:3313–3324. doi: 10.1113/jphysiol.2008.155317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zhang Y, et al. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell. 2003;112:293–301. doi: 10.1016/s0092-8674(03)00071-0. [DOI] [PubMed] [Google Scholar]
  • 46.Van Lommel L, et al. Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes. 2006;55:3214–3220. doi: 10.2337/db06-0774. [DOI] [PubMed] [Google Scholar]
  • 47.Smith PA, Ashcroft FM, Rorsman P. Simultaneous recordings of glucose dependent electrical activity and ATP-regulated K(+)-currents in isolated mouse pancreatic beta-cells. FEBS Lett. 1990;261:187–190. doi: 10.1016/0014-5793(90)80667-8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES